Jade Biosciences (JBIO) Long-Term Debt Issuances (2024)
Jade Biosciences' (JBIO) quarterly Long-Term Debt Issuances came in at $95.0 million in Q4 2024, little changed on a QoQ basis from $95.0 million in Q3 2024.
Powered by 
Analysis
Jade Biosciences (JBIO) Long-Term Debt Issuances (2024) Analysis & Trends
Jade Biosciences (JBIO) has 1 years of Long-Term Debt Issuances data on file, last reported at $95.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Jade Biosciences | 1.22 Bn | 1.22 Bn | - | - |